Old Web
POS-335 COST-EFFECTIVENESS OF DAPAGLIFLOZIN AS A TREATMENT FOR CHRONIC KIDNEY DISEASE: A HEALTH-ECONOMIC ANALYSIS OF DAPA-CKD
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI